Evidence map›Paper›PMID 29484185›Full record

ArticleClinical & translational immunology2018

Accumulation of IL-17

Barbara Polese, Virginie Gridelet, Sophie Perrier d'Hauterive, Chantal Renard, Carine Munaut, Henri Martens, David Vermijlen, Irah L King, Nathalie Jacobs, Vincent Geenen

Open access · goldAbstract read
In one paragraph

Article in Clinical & translational immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. γδ T cells in tissue physiology and surveillance.Nature reviews. Immunology · 2021
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Barbara PoleseGIGA-I3 Center of Immunoendocrinology GIGA Research Institute University of Liege Liege Belgium.ORCID 0000-0002-4400-6477
Virginie GrideletGIGA-I3 Center of Immunoendocrinology GIGA Research Institute University of Liege Liege Belgium.
Sophie Perrier d'HauteriveGIGA-I3 Center of Immunoendocrinology GIGA Research Institute University of Liege Liege Belgium.
Chantal RenardGIGA-I3 Center of Immunoendocrinology GIGA Research Institute University of Liege Liege Belgium.
Carine MunautGIGA Laboratory of Tumor and Development Biology (LBTD) GIGA Research Institute University of Liege Liege Belgium.
Henri MartensGIGA-I3 Center of Immunoendocrinology GIGA Research Institute University of Liege Liege Belgium.
David VermijlenDepartment of Pharmacotherapy and Pharmaceutics and Institute for Medical Immunology Université Libre de Bruxelles (ULB) Bruxelles Belgium.
Irah L KingDepartment of Microbiology and Immunology, Microbiome and Disease Tolerance Centre McGill University Montreal QC Canada.
Nathalie JacobsGIGA-I3 Laboratory of Cellular and Molecular Immunology GIGA Research Institute University of Liege Liege Belgium.
Vincent GeenenGIGA-I3 Center of Immunoendocrinology GIGA Research Institute University of Liege Liege Belgium.
University of Liège · BEMcGill University Health Centre · CAUniversité Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pregnancy is an immune paradox. While the immune system is required for embryo implantation, placental development and progression of gestation, excessive inflammation is associated with pregnancy failure. Similarly, the cytokine IL-17A plays an important role in defence against extracellular pathogens, but its dysregulation can lead to pathogenic inflammation and tissue damage. Although expression of IL-17 has been reported during pregnancy, the cellular source of this cytokine and its relevance to gestation are not clear. Objectives: Here we define the kinetics and cellular source of IL-17A in the uterus during healthy and abortion-prone murine pregnancy. Methods: The CBA/J x DBA/2J abortion-prone mating was used and compared to CBA/J x BALB/c control mating. Results: We demonstrate that, irrespective of gestational health, the number of IL-17-producing cells peaks during midterm pregnancy and is largely derived from the γδ T-cell lineage. We identify γδ T, Th17, CD8 T and NKT cells as the cellular source of IL-17A in pregnant mice. Furthermore, we positively identify the Vγ6 Conclusions: To conclude, the accumulation of uterine IL-17

Indexed as

abortiongamma delta T cellsinterleukin‐17pregnancy

Identifiers

PMID29484185
PMCPMC5822401
OpenAlexW2790039269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.